Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells.

IF 4.3 4区 医学 Q2 IMMUNOLOGY Immune Network Pub Date : 2022-12-01 DOI:10.4110/in.2022.22.e50
Sujin Lee, Jeong In Yang, Joo Hee Lee, Hyun Woo Lee, Tae Jin Kim
{"title":"Low-Level Expression of CD138 Marks Naturally Arising Anergic B Cells.","authors":"Sujin Lee,&nbsp;Jeong In Yang,&nbsp;Joo Hee Lee,&nbsp;Hyun Woo Lee,&nbsp;Tae Jin Kim","doi":"10.4110/in.2022.22.e50","DOIUrl":null,"url":null,"abstract":"<p><p>Autoreactive B cells are not entirely deleted, but some remain as immunocompetent or anergic B cells. Although the persistence of autoreactive B cells as anergic cells has been shown in transgenic mouse models with the expression of B cell receptor (BCR) reactive to engineered self-antigen, the characterization of naturally occurring anergic B cells is important to identify them and understand their contribution to immune regulation or autoimmune diseases. We report here that a low-level expression of CD138 in the splenic B cells marks naturally arising anergic B cells, not plasma cells. The CD138<sup>int</sup> B cells consisted of IgM<sup>low</sup>IgD<sup>high</sup> follicular (FO) B cells and transitional 3 B cells in homeostatic conditions. The CD138<sup>int</sup> FO B cells showed an anergic gene expression profile shared with that of monoclonal anergic B cells expressing engineered BCRs and the gene expression profile was different from those of plasma cells, age-associated B cells, or germinal center B cells. The anergic state of the CD138<sup>int</sup> FO B cells was confirmed by attenuated Ca<sup>2+</sup> response and failure to upregulate CD69 upon BCR engagement with anti-IgM, anti-IgD, anti-Igκ, or anti-IgG. The BCR repertoire of the CD138<sup>int</sup> FO B cells was distinct from that of the CD138<sup>-</sup> FO B cells and included some class-switched B cells with low-level somatic mutations. These findings demonstrate the presence of polyclonal anergic B cells in the normal mice that are characterized by low-level expression of CD138, IgM downregulation, reduced Ca<sup>2+</sup> and CD69 responses upon BCR engagement, and distinct BCR repertoire.</p>","PeriodicalId":13307,"journal":{"name":"Immune Network","volume":"22 6","pages":"e50"},"PeriodicalIF":4.3000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/3f/in-22-e50.PMC9807963.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immune Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4110/in.2022.22.e50","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Autoreactive B cells are not entirely deleted, but some remain as immunocompetent or anergic B cells. Although the persistence of autoreactive B cells as anergic cells has been shown in transgenic mouse models with the expression of B cell receptor (BCR) reactive to engineered self-antigen, the characterization of naturally occurring anergic B cells is important to identify them and understand their contribution to immune regulation or autoimmune diseases. We report here that a low-level expression of CD138 in the splenic B cells marks naturally arising anergic B cells, not plasma cells. The CD138int B cells consisted of IgMlowIgDhigh follicular (FO) B cells and transitional 3 B cells in homeostatic conditions. The CD138int FO B cells showed an anergic gene expression profile shared with that of monoclonal anergic B cells expressing engineered BCRs and the gene expression profile was different from those of plasma cells, age-associated B cells, or germinal center B cells. The anergic state of the CD138int FO B cells was confirmed by attenuated Ca2+ response and failure to upregulate CD69 upon BCR engagement with anti-IgM, anti-IgD, anti-Igκ, or anti-IgG. The BCR repertoire of the CD138int FO B cells was distinct from that of the CD138- FO B cells and included some class-switched B cells with low-level somatic mutations. These findings demonstrate the presence of polyclonal anergic B cells in the normal mice that are characterized by low-level expression of CD138, IgM downregulation, reduced Ca2+ and CD69 responses upon BCR engagement, and distinct BCR repertoire.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CD138的低水平表达标志着自然产生的无能B细胞。
自身反应性B细胞并没有完全被删除,但一些仍然是免疫能力或无能性B细胞。尽管在表达B细胞受体(BCR)对工程化自身抗原反应的转基因小鼠模型中已经显示出自身反应性B细胞作为无能细胞的持久性,但自然产生的无能B细胞的特征对于识别它们并了解它们对免疫调节或自身免疫性疾病的贡献是重要的。我们在此报道,脾B细胞中CD138的低水平表达标志着自然产生的无能B细胞,而不是浆细胞。CD138int B细胞由IgMlowIgDhigh滤泡(FO) B细胞和内稳态条件下的过渡性B细胞组成。CD138int FO B细胞表现出与表达工程化bcr的单克隆无能B细胞相同的无能基因表达谱,而与浆细胞、年龄相关B细胞或生发中心B细胞的基因表达谱不同。在BCR与抗igm、抗igd、抗igκ或抗igg结合时,Ca2+反应减弱和CD69上调失败证实了cd138对FO B细胞的无能状态。CD138int FO B细胞的BCR库与CD138- FO B细胞不同,包括一些低水平体细胞突变的类转换B细胞。这些发现表明,在正常小鼠中存在多克隆无能B细胞,其特征是CD138低表达,IgM下调,BCR参与时Ca2+和CD69反应减少,以及不同的BCR库。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Immune Network
Immune Network Immunology and Microbiology-Immunology
CiteScore
2.90
自引率
3.30%
发文量
36
期刊介绍: Immune Network publishes novel findings in basic and clinical immunology and aims to provide a medium through which researchers in various fields of immunology can share and connect. The journal focuses on advances and insights into the regulation of the immune system and the immunological mechanisms of various diseases. Research that provides integrated insights into translational immunology is given preference for publication. All submissions are evaluated based on originality, quality, clarity, and brevity
期刊最新文献
The Role of Inflammasome-Associated Innate Immune Receptors in Cancer. STING-STAT6 Signaling Pathway Promotes IL-4+ and IFN-α+ Fibrotic T Cell Activation and Exacerbates Scleroderma in SKG Mice. Increased Inflammatory Responses in Patients With Active Disseminated Non-Tuberculous Mycobacterial Infection and High Anti-Interferon-Gamma Autoantibodies. Efficient In Vitro Plasma Cell Differentiation by B Cell Receptor Activation and Cytokine Stimulation. Current Developments in NK Cell Engagers for Cancer Immunotherapy: Focus on CD16A and NKp46.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1